Catalent Pharma Solutions

Article

Sponsored Content

At CPhI North America, Catalent will showcase its OptiForm® Solution Suite and OptiForm Solution Suite Bio, which combine predictive and high throughput screening technologies to identify the most stable and efficient drug form for both small and biological molecules. Using known industry models, multiple formulations are evaluated in parallel and proven delivery technologies employed to offer optimal oral delivery.

Catalent Pharma Solutions
14 Schoolhouse Road, Somerset, NJ 08873
tel. +1 888 SOLUTION
CPhI North America Booth #310

Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

BASF Opens GMP Manufacturing Facility in Michigan

Susan Haigney
June 19th 2025
Article

The new facility offers cleanroom packaging and high-sensitivity analytical testing.

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries

Patrick Lavery
May 30th 2025
Podcast

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.

Cancer detection and screening as a treatment for malignant cells with a biopsy or testing caused by carcinogens and genetics with a cancerous cell as an immunotherapy symbol | Image Credit: © freshidea - stock.adobe.com

Mabion Announces Oncology Services Contest at BIO 2025

Patrick Lavery
June 18th 2025
Article

The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI Frankfurt in October 2025.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

South San Francisco, CA, USA - February 24, 2021: Closeup of a AstraZeneca building corporate office, a British-Swedish pharmaceutical, biotechnology company with its headquarters in Cambridge, England | Image Credit: © Valeriya Zankovych - stock.adobe.com

AstraZeneca Partners on AI-Enabled Research with CSPC Pharmaceuticals

Patrick Lavery
June 13th 2025
Article

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.

Site Logo

Selecting container closure components with confidence: A data-driven approach to container closure integrity

West Pharmaceutical Services
June 13th 2025
Article

Drug products in development require compatible packaging to meet milestones and gain approval. West supports pharmaceutical partners with a data-driven process to give you confidence with closure containment that meets requirements in the modern regulatory landscape.